Oral manifestations of Wegener's granulomatosis: A report of three cases and a literature review

Journal of the American Dental Association

Volumn 138, Issue 3, 2007, Pages 338-348

  Stewart, Carol ^a   Cohen, Donald ^a   Bhattacharyya, Indraneel ^a   Scheitler, Lawrence ^b   Riley, Steven ^c   Calamia, Kenneth ^d   Migliorati, Cesar ^e   Baughman, Ronald ^f   Langford, Perry ^g   Katz, Joseph ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF DENTISTRY   (United States)

^b Bay Pines VA Healthcare System   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

^d MAYO CLINIC   (United States)

^e NOVA SOUTHEASTERN UNIVERSITY   (United States)

^f AmeriPath   (United States)

^g Central Florida ^*

Author keywords

Hyperplastic gingivitis; Wegener's granulomatosis

Indexed keywords

EID: 34047210553     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2007.0166     Document Type: Review

References (75)

1. Wegener F. Über generalisierte, septische efäberkrankungen, Verh Dtsch Pathol Ges 1936;29:202-10.
2. Wegener F. About a peculiar rhinogenic granulomatosis with marked involvement of the arterial system and kidneys. Beitr Pathol Anat 1939;102:30-68.
3. Godman GC, Churg J. Wegener's granulomatosis: pathology and review of the literature. AMA Arch Pathol 1954;58(6):533-53.
4. Cotch MF, Hoffman GS, Yerg DE, Kaufman GI, Targonski P, Kaelow RA. The epidemiology of Wegener's granulomatosis: estimates of the five-year period prevalence, annual mortality, and geographic disease distribution from population-based data sources. Arthritis Rheum 1996 39(1):87-92.
5. Hoffman GS, Kerr GS, Leavitt RY, et al. Wegener granulomatosis: an analysis of 158 patients. Ann Intern Med 1992;116(6):488-98.
6. Hoffman GS, Gross WL. Wegener's granulomatosis: clinical aspects. In: Hoffman GS, Weyand CM, eds. Inflammatory diseases of blood vessels. New York: Marcel Dekker; 2002:381-97.
7. Stegeman CA, Tervaert JW, Sluiter WJ, Manson WL, de Jong PE, Kallenberg CG. Association of chronic nasal carriage of Staphylococcus aureus and higher relapse rates in Wegener granulomatosis. Ann Intern Med 1994;120(1):12-7.
8. Popa ER, Stegeman CA, Kallenberg CG, Tervaert JW. Staphylococcus aureus and Wegener's granulomatosis. Arthritis Res 2002 4(2): 77-9.
9. Capizzi SA, Specks U. Does infection play a role in the pathogenesis of pulmonary vasculitis? Semin Respir Infect 2003;18(1):17-22.
10. Tervaert JW, Stegeman CA, Kallenberg CG. Silicon exposure and vasculitis. Curr Opin Rheumatol 1998;10(1):12-7.
11. Leavitt RY, Fauci AS, Bloch DA, et al. The American College of Rheumatology 1990 criteria for the classification of Wegener's granulomatosis. Arthritis Rheum 1990;33(8):1101-7.
12. Bacon PA. The spectrum of Wegener's granulomatosis and disease relapse. N Engl J Med 2005;352(4):330-2.
13. Fahey JL, Leonard E, Churg J, Godman G. Wegener's granulomatosis. Am J Med 1954;17(2):168-79.
14. Hu CH, O'Loughlin S, Winkelmann RK. Cutaneous manifestations of Wegener's granulomatosis. Arch Dermatol 1977;113(2):175-82.
15. Walton EW. Giant-cell granuloma of the respiratory tract (Wegener's granulomatosis). Br Med J 1958;2(5091):265-70.
16. Carrington CB, Liebow A. Limited forms of angiitis and granulomatosis of Wegener's type. Am J Med 1966;41(4):497-527.
17. Hansen LS, Silverman S, Pons VG, et al. Limited Wegener's granulomatosis: report of a case with oral, renal and skin involvement. Oral Surg Oral Med Oral Pathol 1985;60(5):524-31.
18. Patten SF, Tomecki KJ. Wegener's granulomatosis: cutaneous and oral mucosal disease. J Am Acad Dermatol 1993;28(5 pt 1):710-8.
19. Daoud MS, Gibson Le, DeRemee RA, Specks U, el-Azhary RA, Su WP. Cutaneous Wegener's granulomatosis: clinical, histopathologic, and immunopathologic features of thirty patients. J Am Acad Dermatol 1994;31(4):605-12.
20. Frances C, Du LT, Piette JC, et al. Wegener's granulomatosis: dermatological manifestations in 75 cases with clinicopathologic correlation. Arch Dermatol 1994;130(7):861-7.
21. Fauci AS, Haynes BF, Katz P, Wolff SM. Wegener's granulomatosis: prospective clinical and therapeutic experience with 85 patients for 21 years. Ann Intern Med 1983;98(1):76-85.
22. Cohen PS, Meltzer JA. Strawberry gums: a sign of Wegener's granulomatosis. JAMA 1981;246(22):2610-1.
23. Scott J, Finch LD. Wegener's granulomatosis presenting as gingivitis: review of the clinical and pathologic features and report of a case. Oral Surg Oral Med Oral Pathol 1972;34(6):920-33.
24. Napier SS, Allen JA, Irwin CR, McCluskey DR. 'Strawberry gums': a case of Wegener's granulomatosis. Br Dent J 1993;175(9):327-9.
25. Eufinger H, Machtens E, Akuamoa-Boateng E. Oral manifesta tions of Wegener's granulomatosis: review of the literature and report of a case. Int J Oral Maxillofac Surg 1992;21(1):50-3.
26. Israelaon H, Binnie WH, Hurt WC. The hyperplastic gingivitis of Wegener's granulomatosis. J Feriodontol 1981;52(2):81-7.
27. Porter SR, Scully C. Immunologically mediated disease. In: Jones JH, Mason DK, eds. Oral manifestations of systemic disease. 2nd ed. London: Balliere Tindall; 1990:183-270.
28. Parsons E, Seymour RA, Macleod RI. Wegener's granulomatosis: a distinct gingival lesion. J Clin Periodontol 1992;19(1):64-6.
29. Clark WJ, Broumand V, Ruskin JD, Davenport WL. Erythematous, granular, soft tissue lesion of the gingiva. J Oral Maxillofac Surg 1998;56(8):962-7.
30. Lilly J, Juhlin T, Lew D, Vincent S, Lilly G. Wegener's granulomatosis presenting as oral lesions: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85(2):153-7.
31. Handlers JP, Waterman J, Abrams AM, Melrose RJ. Oral features of Wegener's granulomatosis. Arch Otolaryngol 1985;111(4):267-70.
32. Velez I, Mufson RA, Stern D, Tamara L. Wegener's granulomatosis: a case report. N Y State Dent J 2004 Nov;70(8):26-8.
33. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci U S A 1990;87(11):4115-9.
34. van der Woude FJ, Rasmussen N, Lobatto S, et al. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet 1985;1(8426):425-9.
35. Rao JK, Allen NB, Pincus T. Limitations of the 1990 American College of Rheumatology classification criteria in the diagnosis of vasculitis. Ann Intern Med 1998;129(5):345-52.
36. Cooley P, Taylor KH, Czika W, Seifer C, Taylor JF. Analysis of a biomarker for Wegener's granulomatosis. Int J Immunogenet 2005;32(4):237-43.
37. Hoffman GS, Specks U, Antineutrophil cytoplasmic antibodies. Arthritis Rheum1998;41(9):1521-37.
38. Davenport A. "False positive" perinuclear and cytoplasmic antineutrophil cytoplasmic antibody results leading to misdiagnosis of Wegener's granulomatosis and/or microscopic polyarteritis. Clin Nephrol 1992;37(3):124-30.
39. De Clerck LS, Van Offel JF, Smolders WA, et al. Pitfalls with antineutrophil cytoplasmic antibodies (ANCA). Clin Rheumatol 1989;8(4):512-6.
40. Koderisch J, Andrassy K, Rasmussen N, Hartmann M, Tilgen W. "False-positive" anti-neutrophil cytoplasmic antibodies in HIV infection (letter). Lancet 1990;335(8699):1227-8.
41. Mains B. Wegener's granulomatosis: false positive anti-neutrophil cytoplasmic antibody test. J Laryngol Otol 1989;103(5):B24-5.
42. Esnault VL, Jayne DR, Keogan MT, et al. Anti-neutrophil cytoplasm antibodies in patients with monoclonal gammopathies. J Clin Lab Immunol 1990;32(4):153-9.
43. Alon U, Hellerstein S, Warady BA. Anti-neutrophil cytoplasmic antibodies in drug-induced Wegener-like disease (letter). Pediatr Nephrol 1990;4(3):299-300.
44. Mustonen J, Soppi E, Pasternack A, Hallstrom O. Clinical significance of autoantibodies against neutrophil cytoplasmic components in patients with renal disease. Am J Nephrol 1990;10(6):482-8.
45. Andrassy K, Koderisch J, Rufer M, Erb A, Waldherr R, Ritz E. Detection and clinical implication of anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis and rapidly progressive glomerulonephritis. Clin Nephrol 1989;32(4):159-67.
46. Al Dhanhani A, Macaulay R, Maloney B, Hanly JG. Meningeal involvement in Wegener's granulomatosis. J Rheumatol 2006;33(2): 364-7.
47. Langford CA. The diagnostic utility of c-ANCA in Wegener's granulomatosis. Cleve Clin J Med 1998;65(3):135-40.
48. Lynch JP 3rd, White E, Tazelaar H, Langford CA. Wegener's granulomatosis: evolving concepts in treatment. Semin Respir Crit Care Med 2004;25(5):491-521.
49. Stegeman CA, Tervaert JW, de Jong PE, Kallenberg CG. Trimethoprim- sulfamethoxazole (co-trimaxazole) for the prevalence of relapses of Wegener's granulomatosis. Dutch Co-Trimoxazole Wegener Study Group. N Engl J Med 1996;335(1):16-20.
50. Salem M, Tainsh RE Jr, Bromberg J, Loriaux DL, Chernow B. Perioperative glucocorticoid coverage: a reassessment 42 years after emergence of a problem. Ann Surg 1994;219(4):416-25.
51. Vermeulen JP, Mahowald ML. A case of Wegener's granulomatosis presenting with jaw claudication. J Rheumatol 1984;11(5):707-9.
52. Lhote F, Cohen P, Genereau T, Gayraud M, Guillevin L. Microscopic polyangiitis: clinical aspects and treatment. Ann Med Interne (Paris) 1996;147(3):165-77.
53. Shiboski CH, Regezi JA, Sanchez HC, Silverman S Jr. Oral lesions as the first clinical sign of microscopic polyangiitis: a case report. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2002;94(6):707-11.
54. Jennette JC, Falk RJ, Andrassy K, et al. Nomenclature of systemic vasculitides: proposal of an international consensus conference. Arthritis Rheum 1994;37(2):187-92.
55. White A, Nunes C, Escudier M, et al. Improvement in orofacial granulomatosis on a cinnamon- and benzoate-free diet. Inflamm Bowel Dis 2006;12(6):508-14.
56. Taibjee SM, Frais L, Foulds IS. Orofacial granulomatosis worsened by chocolate: results of patch testing to ingredients of Cadbury's chocolate. Br J Dermatol 2004;150(3):595.
57. Oliver AJ, Rich AM, Reade PC, Varigos GA, Radden BG. Monosodium glutamate-related orofacial granulomatosis: review and case report. Oral Surg Oral Med Oral Pathol 1991;71:560-4.
58. Khamaysi Z, Bergman R, Weltfriend S. Positive patch test reactions to allergens of the dental series and the relation to the clinical presentations. Contact Dermatitis 2006;55(4):216-8.
59. Lazarov A, Kidron D, Tulchinsky Z, Minkow B. Contact orofacial granulomatosis caused by delayed hypersensitivity to gold and mercury. J Am Acad Dermatol 2003;49(6):1117-20.
60. Blinder D, Yahatom R, Taicher S. Oral manifestation of sarcoidosis. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1997;83(4):458-61.
61. Hogan JJ. Sarcoid gingivitis, Br Dent J 1983;154(4):109-10.
62. Hayter JP, Robertson JM. Sarcoidosis presenting as gingivitis. Br Med J (Clin Res Ed) 1988;296(6635):1504.
63. Harty S, Fleming P, Rowland M, et al. A prospective study of the oral manifestations of Crohn's disease. Clin Gastroenterol Hepatol 2005;3(9):886-91.
64. Scheper HJ, Brand HS. Oral aspects of Crohn's disease. Int Dent J 2002;52(3):163-72.
65. Kalmar JR. Crohn's disease: orofacial considerations and disease pathogenesis. Periodontol 2000 1994:6:101-15.
66. Desai P, Silver JG. Drug-induced gingival enlargements. J Can Dent Assoc 1998;64(4):263-8.
67. Uzel MI, Kantarci A, Hong HH, et al. Connective tissue growth factor in drug-induced gingival overgrowth. J Periodontol 2001;72(7):921-31.
68. Dongari A, McDonnell HT, Langlais RP. Drug-induced gingival overgrowth. Oral Surg Oral Med Oral Pathol 1993;74(4):543-8.
69. Barrett AP. Gingival lesions in leukemia: a classification. J Periodontol 1984;55(10):685-8.
70. Hou GL, Tsai CC. Primary gingival enlargement as a diagnostic indicator in acute myelomonocytic leukemia: a case report. J Periodontol 1988;59(12):852-5.
71. Appel BN, Miggantz RJ. Acute nonlymphocytic leukemia, monocytic variant: report of a case. J Periodontol 1988;59(7):464-8.
72. Kolokotronis A, Konstantinou N, Christakis I, et al. Localized B-cell non-Hodgkin's lymphoma of oral cavity and maxillofacial region: a clinical study. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2005;99(3):303-10.
73. Takahashi H, Tezuka F, Fujita S, Okabe H. Primary extranodal non-Hodgkin's malignant lymphoma of the oral region: analysis of 11 autopsy cases. J Oral Pathol 1987;16(5):241-50.
74. Silverman S, Gorsky M, Lozada-Nur F, Liu A. Oral mucous membrane pemphigoid: a study of sixty-five patients. Oral Surg Oral Med Oral Pathol 1986;61(3):233-7.
75. Dayan, S, Simmons RK, Ahmed AR. Contemporary issues in the diagnosis of oral pemphigoid: a selective review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1999;88(4):424-30.